欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

How Aspen’s Priyen Naidu drives a human-centred approach to technology

2026-09-27
Mid-Sized Pharma And Lilly Setting The M&A Pace In 2026

2026-09-27
Bristol Myers Squibb Announces First Presentation of Results for ZENBEXUS™ (iberdomide) in Combination with Daratumumab from Phase 3 EXCALIBER-RRMM Trial in Relapsed or Refractory Multiple Myeloma

2026-09-27
Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

2026-09-27
Merck’s Wnt Agonist Is Efficacious As New Mechanism For Eye Disease

2026-09-26
PRESS RELEASE_Sun Pharma Launches CTaro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System

2026-09-26
Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026

2026-09-26
Mirum’s Atebrioz, First Oral Approved For FOP, To Face Regeneron’s Pasatru

2026-09-26
UK To Close Regulatory Gaps With £20m Research Push

2026-09-26
Formycon Points To Benefits For Early Movers On Biosimilar Streamlining

2026-09-25
Bristol Myers Squibb Presents Sotyktu (deucravacitinib) Data Showing Durable Efficacy, Consistent Safety in Adults with Psoriatic Arthritis Over Two Years

2026-09-25
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 8-10 September 2026

2026-09-25